Recent approaches that have investigated the role of synaptic loss in PSP and CBD aimed to better understand tauopathies by mapping synaptic density based on the affinity for a presynaptic vesicle glycoprotein (SV2A) [85,86]. This evidence concerns the gene SV2A and red-green color blindness.